21.   The statistics show four men who worked there have died of prostate cancer.

22.   Also, a recent medical study from Harvard University has determined that the mineral selenium may help prevent advanced prostate cancer.

23.   Amgen abandoned agreements with Waltham, Mass.-based Praecis Pharmaceuticals Inc. to develop Plenaxis, an experimental treatment for prostate cancer.

24.   Amgen also is scheduled to present the results of phase three studies of a prostate cancer drug, Abarelix, which it developed along with Praecis Pharmaceuticals.

25.   Amgen said the FDA had rejected a new drug for prostate cancer that it is developing with Praecis Pharmaceuticals.

26.   Although the standard treatment for early prostate cancer is to remove the gland, no one has shown that the operation improves the chances of long-term survival.

27.   AlthoughIMRT has been used mainly for prostate cancer, it also is being tested with tumors in the head and neck, lung, breast and brain.

28.   Amgen also announced Tuesday that it has completed the final testing phases for Abarelix, its prostate cancer drug, Kaye said.

29.   Amgen Inc. said the Food and Drug Administration has rejected a new drug for prostate cancer that it is developing with Praecis Pharmaceuticals.

30.   And he might be at greater risk for prostate cancer.